  On the basis of clinical trials using first-generation epidermal growth factor receptor ( EGFR) tyrosine kinase inhibitors ( TKIs) , it became a doctrine that V-Ki-ras2 Kirsten rat sarcoma<disease> viral oncogene homolog (